TET2 might be a therapeutic target for atherosclerosis

被引：1
|
作者：
Wang, Yu [1 ]
Zhao, Danyang [2 ]
Lu, Ping [1 ]
Sheng, Jing [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Geriatr, Shanghai 200011, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, Shanghai 200011, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 203卷
关键词：
DNA METHYLATION;
D O I：
10.1016/j.ijcard.2015.10.052
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：396 / 397
页数：2
相关论文
共 50 条
  • [21] Low Regimen Therapeutic Strategies to Mitigate TET2 Mutant Clonal Hematopoiesis
    Jiang, Dongxu
    Vail, Daniel J.
    Zhang, Yahan
    Khan, Raziullah
    Tiwari, Anand
    Schlanger, Simon
    Chung, Kunho
    Gilmour, Cassandra
    Gu, Xiaorong
    Parker, Yvonne
    Melenhorst, J. Joseph
    Lindner, Daniel
    Maciejewski, Jaroslaw
    Jha, Babal K.
    BLOOD, 2024, 144 : 2664 - 2665
  • [22] The role of TET2 in solid tumors and its therapeutic potential: a comprehensive review
    Da, Wenxin
    Song, Ziyu
    Liu, Xiaodong
    Wang, Yahui
    Wang, Shengjun
    Ma, Jie
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (09): : 2156 - 2165
  • [23] Impact of Tet2 Deficiency, and of TET2 Mutations in Clonal Hematopoiesis, on Neutrophil/Granulocyte Immune Function
    Cook, Elina K.
    Luo, Michael
    Mewburn, Jeffrey
    Dunham-Snary, Kimberly J.
    Hindmarch, Charles
    Archer, Stephen L.
    Rauh, Michael J.
    BLOOD, 2021, 138
  • [24] Dysregulation of TET2 in hematologic malignancies
    Shigeru Chiba
    International Journal of Hematology, 2017, 105 : 17 - 22
  • [25] TET2, an “ambiguous” player in inflammation
    Ana María Espinosa-Oliva
    Miguel Angel Burguillos
    Neural Regeneration Research, 2020, 15 (08) : 1481 - 1482
  • [26] TET2 mutations in childhood leukemia
    Langemeijer, S. M. C.
    Jansen, J. H.
    Hooijer, J.
    van Hoogen, P.
    Stevens-Linders, E.
    Massop, M.
    Waanders, E.
    van Reijmersdal, S. V.
    Stevens-Kroef, M. J. P. L.
    Zwaan, C. M.
    van den Heuvel-Eibrink, M. M.
    Sonneveld, E.
    Hoogerbrugge, P. M.
    van Kessel, A. Geurts
    Kuiper, R. P.
    LEUKEMIA, 2011, 25 (01) : 189 - 192
  • [27] The Potential Equivalents of TET2 Mutations
    Pasca, Sergiu
    Jurj, Ancuta
    Zdrenghea, Mihnea
    Tomuleasa, Ciprian
    CANCERS, 2021, 13 (07)
  • [28] TET2: the fat controller of leptin
    Callen C.Goldsmith
    Garron T.Dodd
    Life Metabolism, 2024, 3 (04) : 14 - 16
  • [29] Mutation in TET2 in Myeloid Cancers
    Delhommeau, Francois
    Dupont, Sabrina
    Della Valle, Veronique
    James, Chloe
    Trannoy, Severine
    Masse, Aline
    Kosmider, Olivier
    Le Couedic, Jean-Pierre
    Robert, Fabienne
    Alberdi, Antonio
    Lecluse, Yann
    Plo, Isabelle
    Dreyfus, Francois J.
    Marzac, Christophe
    Casadevall, Nicole
    Lacombe, Catherine
    Romana, Serge P.
    Dessen, Philippe
    Soulier, Jean
    Viguie, Franck
    Fontenay, Michaela
    Vainchenker, William
    Bernard, Olivier A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (22): : 2289 - 2301
  • [30] TET2 mutations in childhood leukemia
    S M C Langemeijer
    J H Jansen
    J Hooijer
    P van Hoogen
    E Stevens-Linders
    M Massop
    E Waanders
    S V van Reijmersdal
    M J P L Stevens-Kroef
    C M Zwaan
    M M van den Heuvel-Eibrink
    E Sonneveld
    P M Hoogerbrugge
    A Geurts van Kessel
    R P Kuiper
    Leukemia, 2011, 25 : 189 - 192
12345